125 related articles for article (PubMed ID: 16985093)
1. Use of non-aspirin nonsteroidal antiinflammatory drugs and the risk of cardiovascular events.
Cheng JW
Ann Pharmacother; 2006 Oct; 40(10):1785-96. PubMed ID: 16985093
[TBL] [Abstract][Full Text] [Related]
2. The effects of nonselective non-aspirin non-steroidal anti-inflammatory medications on the risk of nonfatal myocardial infarction and their interaction with aspirin.
Kimmel SE; Berlin JA; Reilly M; Jaskowiak J; Kishel L; Chittams J; Strom BL
J Am Coll Cardiol; 2004 Mar; 43(6):985-90. PubMed ID: 15028354
[TBL] [Abstract][Full Text] [Related]
3. Potential limitations of electronic database studies of prescription non-aspirin non-steroidal anti-inflammatory drugs (NANSAIDs) and risk of myocardial infarction (MI).
Ilkhanoff L; Lewis JD; Hennessy S; Berlin JA; Kimmel SE
Pharmacoepidemiol Drug Saf; 2005 Aug; 14(8):513-22. PubMed ID: 15959879
[TBL] [Abstract][Full Text] [Related]
4. Cardiovascular events associated with the use of four nonselective NSAIDs (etodolac, nabumetone, ibuprofen, or naproxen) versus a cyclooxygenase-2 inhibitor (celecoxib): a population-based analysis in Taiwanese adults.
Huang WF; Hsiao FY; Wen YW; Tsai YW
Clin Ther; 2006 Nov; 28(11):1827-36. PubMed ID: 17213003
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis: cardiovascular events associated with nonsteroidal anti-inflammatory drugs.
Salpeter SR; Gregor P; Ormiston TM; Whitlock R; Raina P; Thabane L; Topol EJ
Am J Med; 2006 Jul; 119(7):552-9. PubMed ID: 16828623
[TBL] [Abstract][Full Text] [Related]
6. Impact of nonsteroidal antiinflammatory drugs on the cardioprotective effects of aspirin.
Corman SL; Fedutes BA; Ansani NT
Ann Pharmacother; 2005 Jun; 39(6):1073-9. PubMed ID: 15870140
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events.
Chan AT; Manson JE; Albert CM; Chae CU; Rexrode KM; Curhan GC; Rimm EB; Willett WC; Fuchs CS
Circulation; 2006 Mar; 113(12):1578-87. PubMed ID: 16534006
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular thromboembolic adverse effects associated with cyclooxygenase-2 selective inhibitors and nonselective antiinflammatory drugs.
Joshi GP; Gertler R; Fricker R
Anesth Analg; 2007 Dec; 105(6):1793-804, table of contents. PubMed ID: 18042885
[TBL] [Abstract][Full Text] [Related]
9. Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs.
Maillard M; Burnier M
Expert Opin Drug Saf; 2006 Jan; 5(1):83-94. PubMed ID: 16370958
[TBL] [Abstract][Full Text] [Related]
10. Risk of cardiovascular events in patients receiving celecoxib: a meta-analysis of randomized clinical trials.
White WB; West CR; Borer JS; Gorelick PB; Lavange L; Pan SX; Weiner E; Verburg KM
Am J Cardiol; 2007 Jan; 99(1):91-8. PubMed ID: 17196469
[TBL] [Abstract][Full Text] [Related]
11. The balance between severe cardiovascular and gastrointestinal events among users of selective and non-selective non-steroidal anti-inflammatory drugs.
van der Linden MW; van der Bij S; Welsing P; Kuipers EJ; Herings RM
Ann Rheum Dis; 2009 May; 68(5):668-73. PubMed ID: 18495734
[TBL] [Abstract][Full Text] [Related]
12. An evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugs.
Farkouh ME; Greenberg BP
Am J Cardiol; 2009 May; 103(9):1227-37. PubMed ID: 19406264
[TBL] [Abstract][Full Text] [Related]
13. Management of patients on nonsteroidal anti-inflammatory drugs: a clinical practice recommendation from the First International Working Party on Gastrointestinal and Cardiovascular Effects of Nonsteroidal Anti-inflammatory Drugs and Anti-platelet Agents.
Chan FK; Abraham NS; Scheiman JM; Laine L;
Am J Gastroenterol; 2008 Nov; 103(11):2908-18. PubMed ID: 18853980
[TBL] [Abstract][Full Text] [Related]
14. Appropriate use of NSAIDs: considering cardiovascular risk in the elderly.
Stillman MJ; Stillman MT
Geriatrics; 2007 Mar; 62(3):16-21. PubMed ID: 17346094
[TBL] [Abstract][Full Text] [Related]
15. Risk of acute myocardial infarction with nonselective non-steroidal anti-inflammatory drugs: a meta-analysis.
Singh G; Wu O; Langhorne P; Madhok R
Arthritis Res Ther; 2006; 8(5):R153. PubMed ID: 16995929
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of rare events: an update and sensitivity analysis of cardiovascular events in randomized trials of rosiglitazone.
Dahabreh IJ; Economopoulos K
Clin Trials; 2008; 5(2):116-20. PubMed ID: 18375649
[TBL] [Abstract][Full Text] [Related]
17. Effects of long-term exposure to traffic-related air pollution on respiratory and cardiovascular mortality in the Netherlands: the NLCS-AIR study.
Brunekreef B; Beelen R; Hoek G; Schouten L; Bausch-Goldbohm S; Fischer P; Armstrong B; Hughes E; Jerrett M; van den Brandt P
Res Rep Health Eff Inst; 2009 Mar; (139):5-71; discussion 73-89. PubMed ID: 19554969
[TBL] [Abstract][Full Text] [Related]
18. Rationale, design, and governance of Prospective Randomized Evaluation of Celecoxib Integrated Safety versus Ibuprofen Or Naproxen (PRECISION), a cardiovascular end point trial of nonsteroidal antiinflammatory agents in patients with arthritis.
Becker MC; Wang TH; Wisniewski L; Wolski K; Libby P; Lüscher TF; Borer JS; Mascette AM; Husni ME; Solomon DH; Graham DY; Yeomans ND; Krum H; Ruschitzka F; Lincoff AM; Nissen SE;
Am Heart J; 2009 Apr; 157(4):606-12. PubMed ID: 19332185
[TBL] [Abstract][Full Text] [Related]
19. Cyclooxygenase-2 inhibitors and most traditional nonsteroidal anti-inflammatory drugs cause similar moderately increased risks of cardiovascular disease.
Hennekens CH; Borzak S
J Cardiovasc Pharmacol Ther; 2008 Mar; 13(1):41-50. PubMed ID: 18287589
[TBL] [Abstract][Full Text] [Related]
20. Risk of serious upper gastrointestinal toxicity with over-the-counter nonaspirin nonsteroidal anti-inflammatory drugs.
Lewis JD; Kimmel SE; Localio AR; Metz DC; Farrar JT; Nessel L; Brensinger C; McGibney K; Strom BL
Gastroenterology; 2005 Dec; 129(6):1865-74. PubMed ID: 16344055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
